Results 221 to 230 of about 43,190 (248)

OBESITY PARADOX FOR STROKE IN PATIENTS WITH ATRIAL FIBRILLATION TREATED WITH RIVAROXABAN AND WARFARIN IN THE ROCKET AF TRIAL

, 2014
Somasekhara R. Balla, Derek D. Cyr, Yuliya Lokhnygina, Richard C. Becker, Scott D. Berkowitz, G Breithardt, Robert M. Califf, Keith A.A. Fox, Werner Hacke, Jonathan L. Halperin, Graeme J. Hankey, Kenneth W. Mahaffey, Christopher C. Nessel, Jonathan P. Piccini, Daniel E. Singer, Manesh R. Patel   +15 more
openalex   +1 more source

Effect of the frequently used antiepileptic drugs carbamazepine, gabapentin, and pregabalin on the pharmacokinetics of edoxaban and other oral factor xa inhibitors in healthy volunteers. [PDF]

Front Pharmacol
Lenard A, Hermann SA, Stoll F, Burhenne J, Foerster KI, Czock D, Mikus G, Meid AD, Haefeli WE, Blank A.   +9 more
europepmc   +1 more source

Rapid Determination of Xa Inhibitor Activity in Blood Using a Microfluidic Device that Measures Platelet Deposition and Fibrin Generation Under Flow. [PDF]

TH Open
Rossi JM, Panckeri KA, Ghosh S, Grosser T, Cuker A, Diamond SL.   +5 more
europepmc   +1 more source

Retracted: Spontaneous rectus sheath haematoma associated with rivaroxaban treatment

, 2014
Ayça Taş Tuna, Onur Palabıyık, Serbülent Gökhan Beyaz   +2 more
openalex   +1 more source

COMBINATION OF ASA WITH DABIGATRAN OR RIVAROXABAN INCREASES RISK OF BLEEDING WITHOUT ADDITIONAL BENEFIT OF STROKE REDUCTION IN PATIENTS WITH ATRIAL FIBRILLATION

, 2014
Anton Strunets, Mahek Mirza, Chi Cho, Jasbír Sra, Arshad Jahangir   +4 more
openalex   +1 more source

Optimal duration of anticoagulation after left atrial appendage closure: a systematic review and meta-analysis. [PDF]

BMC Cardiovasc Disord
Lu X, Yang Z, Fang W, Niu X, Wang Q, Li Y.   +5 more
europepmc   +1 more source

Rivaroxaban versus dalteparin for the treatment of cancer-associated venous thromboembolism: a systematic review and meta-analysis. [PDF]

Ann Med Surg (Lond)
Shrestha B, Bhusal S, Kandel G, Bastakoti S, Yadav KK.   +4 more
europepmc   +1 more source

Safety and Efficacy of Direct Oral Anticoagulants Apixaban and Rivaroxaban Versus Standard Therapy for VTE Prophylaxis Post Cancer Surgery-A Network Meta-Analysis of Randomized Clinical Trials. [PDF]

J Clin Med
Shahbar A, Alawlqi A, Alhifany A, Noor A, Almutairi AR, Alnuhait M.   +5 more
europepmc   +1 more source

Immunomodulatory Effect of Rivaroxaban Nanoparticles Alone and in Combination with Sitagliptin on Diabetic Rat Model. [PDF]

Diseases
Elbadr MM, Galal HA, Hetta HF, Elfadil H, Alanazi FE, Fawzy S, Aljohani HM, Abd Ellah NH, Ali MF, Dyab AK, Ahmed EA.   +10 more
europepmc   +1 more source

Preparation of Carrier-Free Inhalable Dry Powder of Rivaroxaban Using Two-Step Milling for Lung-Targeted Delivery. [PDF]

Pharmaceutics
Kim YJ, Son J, Han CS, Park CW.
europepmc   +1 more source